Brazilian beef is a dubious dish for US investors - FT中文网
登录×
电子邮件/用户名
密码
记住我
请输入邮箱和密码进行绑定操作:
请输入手机号码,通过短信验证(目前仅支持中国大陆地区的手机号):
请您阅读我们的用户注册协议隐私权保护政策,点击下方按钮即视为您接受。
FT商学院

Brazilian beef is a dubious dish for US investors

World’s largest meat processor has long coveted a stateside listing

American meat eaters may not have heard of JBS, but chances are they have sampled its wares. Now, the Brazilian meat processor, the largest in the world, wants them to sample its shares, too.

JBS supplies much of the beef, pork and poultry that ends up on American plates, and the reliance is mutual. More than half of the $77.2bn in revenue it pulled in last year came from the US. That exposure is one reason the company has long coveted a US share listing. Having pursued the idea on and off for close to a decade, the company finally got the green light from regulators and its shareholders to move its main stock listing from Brazil to the US.

The company thinks the move will help its stock, which trades at a sharp discount to US rivals, fetch a higher valuation as well as give the company access to cheaper funding.

The shares will not be palatable to everyone, though. The founding Batista family, through its investment vehicles, is the largest shareholder in JBS with a 48 per cent stake. The planned issue of supervoting shares, offered disproportionately to the Batista family, could leave it with 85 per cent of votes. 

Shareholder advisory firms ISS and Glass Lewis both recommended holders of JBS’s current Brazilian shares to vote against the dual listing — to no avail. Long-standing environmental concerns over the impact of cattle ranching on the Amazon rainforest and a bribery scandal that resulted in the US Securities and Exchange Commission hitting JBS and the Batista brothers with multimillion-dollar penalties could keep the shares off the menus of ESG-minded institutional investors.

Even without these oddities, selling meat is a tough business. High grain and cattle prices are driving up costs for meatpackers. A tough economy also means the scope to pass on the higher costs to consumers has become more limited. While 2024 revenue at JBS was up by a fifth since 2021, profitability is 50 per cent lower.

Despite the run-up in share price in the wake of its US listing approval, JBS currently trades on just five times EV to ebitda. By contrast, Tyson Foods is on a multiple of nine times, while Smithfield Foods and Hormel Foods are on seven and 12 times, respectively A US listing, by virtue of potential index inclusion and lower funding costs, should help narrow this valuation gap.

Even then, compared with US rivals, JBS’s business mix leans more towards low-margin beef processing instead of higher-margin processed foods. Acquisitions might help. To close the valuation gap fully, Brazil’s king of beef will have to change much more than its stock market listing.

pan.yuk@ft.com

版权声明:本文版权归FT中文网所有,未经允许任何单位或个人不得转载,复制或以任何其他方式使用本文全部或部分,侵权必究。

美国在疫苗问题上不幸倒退

2025年对免疫科学来说是丰收的一年,但对美国来说并非如此。

特朗普加速欧洲的电动汽车清算时刻

随着美国车企在政治庇护下放缓电动汽车研发,亚洲车企有望加速扩大规模,这将让欧洲受到更大冲击。

Lex专栏:一出没有反派的反垄断大戏

围绕美国媒体帝国华纳兄弟探索的争夺,将催生出一系列产业及法律的棘手难题。

Netflix对阵派拉蒙:政治或将决定这场收购大战

反垄断担忧以及与特朗普政府的关联,使谁将最终收购华纳兄弟探索的前景变得更加复杂。

AI是一场泡沫吗?

鉴于对AI需求的增长充满不确定性,毫无疑问,投资者们的行为带有投机性。

减重药物需求强劲正带来新的商业现实

两年间,英国已有250万人采购新一代抑制食欲药物,仅过去六个月就新增100万。
1天前
设置字号×
最小
较小
默认
较大
最大
分享×